Victor Ambros and Gary Ruvkun have been awarded the Nobel Prize in Physiology or Medicine jointly this year for their discovery of microRNA and its role in post-transcriptional gene regulation.
This year’s Nobel Prize focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery for protein production. There, mRNAs are translated so that proteins are made according to the genetic instructions stored in DNA. Since the mid-20th century, several of the most fundamental scientific discoveries have explained how these processes work.
Victor Ambros and Gary Ruvkun were interested in how different cell types develop. They discovered microRNA, a new class of tiny RNA molecules that play a crucial role in gene regulation. Their groundbreaking discovery revealed a completely new principle of gene regulation that turned out to be essential for multicellular organisms, including humans. It is now known that the human genome codes for over one thousand microRNAs. Their surprising discovery revealed an entirely new dimension to gene regulation. MicroRNAs are proving to be fundamentally important for how organisms develop and function.
Ambrose performed the research that led to his prize at Harvard University. He is currently a professor of natural science at the University of Massachusetts Medical School. Rackham’s research was performed at Massachusetts General Hospital and the Harvard Medical School, where he’s a professor of genetics, said Thomas Perlmann, Secretary-General of the Nobel Committee.
Also Read: Nobel Prize 2023 in Economic Sciences Awarded to Claudia Goldin
/pratidin/media/agency_attachments/2024/11/06/2024-11-06t060101441z-pratidin-logo.png){kind=logo}
Follow Us/pratidin/media/post_attachments/pratidintime/2024-10-07/4b9nhfeb/Victor-Ambros-and-Gary-Ruvkun-Awarded-Nobel-Prize-in-Medicine.png)